Photo from medicinespatentpool.org
Jun 22, 2023, 18:35
Generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis’ nilotinib – Medicines Patent Pool
Breaking | 4 generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis,’ nilotinib for the treatment of chronic myeloid leukaemia.
The four generic manufacturers companies include:
- Eugia Pharma Specialities Ltd (INDIA)
- Hetero (INDIA)
- Dr. Reddy’s Laboratories (INDIA)
- PT. Brightgene Biomedical Indonesia (INDONESIA)
Source: /Linkedin